Position in GMAB
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,413,617
-$214,224 QoQ
Shares Held
52,688
-0.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 85.80321894928636.ToString("F0")%
Shared 0.ToString("F0")%
None 14.196781050713636.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Derivatives in GMAB
reported options exposure · as of Dec 31, 2020CallValue
$2,545,316
CallShares
62,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $580,215,891 across 80 Biotechnology names. GMAB ranks #28 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,476 | $174,363,150 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,055,597 | $68,223,231 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,524 | $66,079,260 | |
| 4 | ARGX |
Argenx SE
|
85,333 | $62,314,421 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
239,265 | $45,233,045 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
86,183 | $17,206,434 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
515,328 | $17,119,195 | |
| 8 | INCY |
Incyte Corp
|
171,790 | $16,168,871 |
All Filings in GMAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,413,617 | 52,688 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,627,841 | 52,852 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,312,521 | 42,795 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $827,555 | 40,056 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $793,164 | 40,509 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $670,113 | 32,109 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,848,465 | 75,819 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,934,681 | 76,987 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,356,607 | 78,790 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,031,550 | 63,805 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $2,553,828 | 72,408 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $1,260,485 | 33,162 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $1,270,623 | 33,650 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $1,509,955 | 35,629 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $1,162,686 | 36,187 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,156,706 | 35,602 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,314,707 | 36,338 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,543,709 | 39,022 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,645,303 | 37,650 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,482,658 | 36,313 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $340,609 | 10,375 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $373,257 | 9,180 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $2,545,316 | 62,600 | Call | Defined | 2021-02-12 | |
| 2020-09-30 | $276,112 | 7,542 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $152,877 | 4,511 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $91,497 | 4,318 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||